Product Information
DOXYLAMINE-PYRIDOXINE 10-10 MG is a generic product labeled by Endo USA Inc., priced at $1.1455 per EA under NDC 49884018601. Its NADAC has been published 341 times since Feb 12, 2020.
FDA first approved this application on Dec 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DOXYLAMINE-PYRIDOXINE 10-10 MG
Doxylamine Succinate and Pyridoxine Hydrochloride, Delayed release Tablets 10 mg/10 mgStrength
10; 10 mg/1; mg/1
Manufacturer
Endo USA Inc.NDC
49884018601
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208518FDA Approved
12/6/2017
TE Code
AB
On Market Since
12/19/2019
Pharmacological Classes
Price Statistics
The NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has been published 341 times since Feb 12, 2020, and over the history we have for it it has declined 74.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1455 per EA |
|---|---|
| All-time high | $5.3468 (Sep 15, 2021) |
| All-time low | $0.9736 (Jul 17, 2024) |
| 52-week high | $1.3056 |
| 52-week low | $1.1365 |
| Median price | $2.0427 |
| Average price | $2.4700 |
| Largest weekly change | +68.5% (Jun 19, 2024) |
| Weeks tracked | 341 |
| Tracking since | Feb 12, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Doxylamine Succinate and Pyridoxine Hydrochloride, Delayed release Tablets 10 mg/10 mg market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXYLAMINE-PYRIDOXINE 10-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for DOXYLAMINE-PYRIDOXINE 10-10 MG, manufactured by Endo USA Inc., is $1.1455 per EA (NDC 49884018601), effective Aug 19, 2026.
How has the price of DOXYLAMINE-PYRIDOXINE 10-10 MG changed over time?
Over the history we have for it, the NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has declined 74.5%. It has been tracked across 341 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for DOXYLAMINE-PYRIDOXINE 10-10 MG?
Since Feb 12, 2020, the NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has ranged from a low of $0.9736 (Jul 17, 2024) to a high of $5.3468 (Sep 15, 2021), with a median of $2.0427 per EA.
Are there cheaper alternatives to DOXYLAMINE-PYRIDOXINE 10-10 MG?
No other NADAC-published product currently shares the active ingredient and strength of DOXYLAMINE-PYRIDOXINE 10-10 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXYLAMINE-PYRIDOXINE 10-10 MG?
DOXYLAMINE-PYRIDOXINE 10-10 MG (NDC 49884018601) is labeled by Endo USA Inc., and CMS classifies it as a generic product.